Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)
If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.
Sign up for our newsletter below to receive updated information.
**Ensure you receive all the latest news on research, events, the Torch and support by keeping your email up to date and including WMFC and IWMF as trusted senders as well as keeping your mailing address up to date.
Article: Reducing Dose Intensity May Be Associated with Shortened PFS in Waldenstrom Macroglobulinemiahttps://www.cancertherapyadvisor.com/hematologic-cancers/waldenstrom-macroglobulinemia-lower-dosage-intensity-shorter-survival/article/767850/ Reducing Dose Intensity May Be Associated with Shortened PFS in Waldenstrom Macroglobulinemia James Nam, PharmD May 22, 2018 Share this content: Decreasing the dose intensity (DI) of ibrutinib mayRead More
Article: High Rates of Response, Survival With Ibrutinib Plus Rituximab in Waldenström MacroglobulinemiaHigh Rates of Response, Survival With Ibrutinib Plus Rituximab in Waldenström Macroglobulinemia Saturday, June 2, 2018 Treatment with a combination of ibrutinib and rituximab improved progression-free survival (PFS) over rituximabRead More